Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns
Tuesday, April 16, 2019 - 10:20
in Health & Medicine
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.